#Longevity

3 articles with this tag

Sam Altman Net Worth 2026: His $3.3B Portfolio Across Helion, Worldcoin, and Retro Biosciences

OpenAI closed a $122 billion funding round at an $852 billion valuation in March 2026. Here is a company-by-company breakdown of every venture Sam Altman controls or has materially funded, from Helion Energy at $15.5 billion to Retro Biosciences at $1.8 billion.

3 months ago

Technology

Cialis Longevity Hype Faces Skepticism

Tadalafil (Cialis) is trending in biohacking for longevity, but experts caution against unproven claims, citing a lack of rigorous evidence.

5 months ago

Artificial Intelligence

Huberman & Wolf on Peptides, AI, and Longevity

Neuroscientist Andrew Huberman and a16z partner Daisy Wolf discuss the future of AI in health, the rise of peptides, and the growing trend of proactive self-care.

8 months ago